Clinical Trials Logo

Clinical Trial Summary

This multi-site, pilot study will assess vitamin D supplementation in children and young adults with Glomerular Disease. .


Clinical Trial Description

Vitamin D deficiency has been linked to a variety of adverse health outcomes. Nephrotic patients have very low vitamin D levels, and the underlying mechanisms are not known. Furthermore, approaches to safely and effectively supplement vitamin D in these patients have not been established. The purpose of this research study is to learn if vitamin D supplementation is safe and effective in patients with primary glomerular disease and to also help establish the treatment guidelines. About 35 patients with primary glomerular disease, ages 5-30 years old, will take part in this study. Participants will be asked to take vitamin D supplements each day for 12 weeks and will have 3 study visits. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01835639
Study type Interventional
Source Children's Hospital of Philadelphia
Contact
Status Completed
Phase N/A
Start date April 2013
Completion date September 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02216747 - Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse Phase 4
Recruiting NCT01240564 - The Nephrotic Syndrome Study Network (NEPTUNE) N/A
Recruiting NCT04987450 - Effect of Glucocorticoids on Inflammation and Bone Metabolism in Patients With Glomerular Disease
Completed NCT00255398 - Kidney Disease Biomarkers
Recruiting NCT04380610 - Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia
Recruiting NCT03929887 - KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
Completed NCT01090037 - TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis) Phase 2/Phase 3
Recruiting NCT04528446 - The Impact of Glomerular Disorders on Bone Quality and Strength
Not yet recruiting NCT05875454 - Podocyts Integrity in Glomerular Diseases
Completed NCT04287985 - Safety and Efficacy Study of VIS649 for IgA Nephropathy Phase 2
Recruiting NCT04939116 - Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease Phase 2
Recruiting NCT00977977 - Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy Phase 2
Terminated NCT03607500 - Effect of Moderate Caloric Restriction on Glomerular Growth After Kidney Transplantation N/A
Recruiting NCT05505500 - Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
Completed NCT00001392 - Pathogenesis of Glomerulosclerosis